Jump to:Page Content
The settlement resolves RICO and other claims brought in dozens of class actions against Merck/Schering-Plough Pharmaceuticals, alleging the companies misrepresented the drugs’ effectiveness in reducing the risk of heart disease and concealed study results. In re: Vytorin/Zetia Mktg., Sales Pracs. & Prods. Liab. Litig.